Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Advanced Microtubular Colorectal Adenomas: A 10-Year Survey at a Single Hospital

CARLOS A. RUBIO and EDGAR JARAMILLO
Anticancer Research December 2013, 33 (12) 5471-5476;
CARLOS A. RUBIO
1Department of Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Carlos.Rubio@ki.se
EDGAR JARAMILLO
2Department of Gastroenterology, Karolinska Institute and University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Colorectal carcinoma, the third most commonly diagnosed type of cancer in Europe and the USA, usually originates from colorectal adenoma (CRA). Three main histological phenotypes of CRA are usually recognized: tubular, villous and traditional serrated (TA, VA and TSA, respectively). In 1997, we reported a novel histological phenotype, the microtubular adenoma (MTA), epitomized by dysplastic epithelium arranged in closed rings (microtubules), with sideways-elongated outgrowth. Materials and Methods: The material includes 4,446 CRAs diagnosed at our Department during a 10-year period (2001-2010). Results: Out of 4,446 CRAs, 68 (1.5%) were MTA; of these, 38 (55.9%) exhibited low-grade dysplasia (LGD), 17 (25.0%), high-grade-dysplasia, two (2.9%) intraepithelial carcinoma and three (4.4%), intramucosal carcinoma. Out of the 68 MTA, 22 (32.3%) were advanced MTA. Submucosal carcinoma (SMC) was present in eight (11.8%) MTAs. Ninety-four per cent (64/68) of the MTAs were left-sided adenomas. In previous work, we found that cell proliferation occurred in the dysplastic microtubules in MTA, initially in the luminal dysplastic epithelium in TA and VA, and initially at the bottom of the serrated dysplastic crypts in TSA. Conclusion: Due to these distinctive microscopic and cell proliferative attributes, a predominant left-sided location and the absence of serrated configurations, it is submitted that MTA is a specific CRA phenotype, at variance with TA, VA, and TSA. The high frequency of SMC strongly suggests that MTA is an important alternative pathway in colorectal carcinogenesis.

  • Advanced adenomas
  • microtubular configurations
  • invasive carcinoma
  • colorectal adenoma

Colorectal carcinoma (CRC), the third most commonly diagnosed type of cancer in Europe and the USA (1) usually originates in mucosal foci of mutated cells with proliferative, biochemical and molecular aberrations; they are referred to as colorectal adenomas (CRA) (2). Less frequently, CRC develops from dysplastic crypts in patients with ulcerative colitis (3), from specialized epithelial cells covering gut-associated lymphoid tissue (4), or from mucosa without any recognizable preceding dysplastic alteration (de novo carcinoma) (5, 6).

Based on the structural histological configuration, CRAs have been classically classified into tubular (TA), villous (VA) and serrated (SA) subtypes. SA exhibits dysplastic, teeth-like outlines that resemble serrations in a saw; today this lesion is referred to as traditional serrated adenoma (TSA) (7). In 1997, in Japanese patients we found a CRA that was at variance with the aforementioned histological phenotypes, as it displayed closed dysplastic microtubules arranged in a sequential fashion along the slopes of epithelial outgrowths (8). Initially called villo-microglandular adenoma (8) it was later re-named microtubular adenoma (MTA) by the WHO in 2000 (9). Since its description in Japanese patients, MTAs have been also reported in Swedish (10), Italian (11) and English (12) patients. In previous work, we found that cell proliferation in MTA occurred in the dysplastic microtubules (10, 11), in TA and VA initially in the luminal dysplastic epithelium (9, 13), and in TSA initially at the bottom of serrated dysplastic crypts (14).

Based on the degree of cellular dysplasia, CRAs were classified into those exhibiting slight, moderate or severe dysplasia by some (15), and low and high-grade dysplasia (LGD and HGD, respectively), by others (16). More recently, the concept of advanced CRA (17) has received wide acceptance due to its association with invasive carcinoma (18-20). However, the definition of advanced CRA varies. Some authors regard it as those adenomas measuring >1 cm in diameter (21, 22), others >1 cm in diameter with villous histology (23-25); others require the presence of HGD (26-28); others, at least 1 cm or with villous elements at a frequency greater than 20% or with HGD (29); and others as carcinoma in situ (intraepithelial carcinoma, IEC) (30-32). Finally, some authors require the presence of intramucosal carcinoma (IMC) (20, 33-35).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Microtubular adenoma showing sideways dysplastic microtubules (H&E, ×4).

In earlier work of ours, we investigated 92 consecutive CRAs with submucosal carcinoma (SMC) and either HGD or IEC in the remnant adenomatous tissue (36). Although submucosal invasion occurred more frequently in CRA with IEC than in those with HGD, as many as 42% of the SMCs arose in CRA with HGD exclusively. Despite morphological, histochemical and immunohistochemical dissimilarities between the two lesions (37, 38), it was concluded that both HGD and IEC have a propensity to invade host tissue. Against this background, CRA with HGD and with IEC were regarded here as advanced CRA. In addition, and in concordance with other authors (33-35), adenomas with IMC were also regarded as advanced CRA.

The purpose of the present work was to assess, i) the frequency of MTA and ii) the frequency of advanced MTA, in a cohort of CRAs diagnosed between 2001 and 2010 at this Department.

Materials and Methods

The material comprised of 4,446 polypectomies exhibiting CRA at histology, diagnosed at the Department of Pathology, Karolinska University Hospital during a 10-year period (2001-2010). A total of 3,456 CRAs were diagnosed by the author (CR); and the remaining 990 CRAs by other pathologists at the Department. Sections from these 990 CRAs were retrieved from the files and reviewed; the aim was to detect possible unreported cases of MTA.

TA, VA and TSA were excluded from the study, as sessile serrated polyps.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Microtubular adenoma with high-grade dysplasia. (H&E, ×40).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Microtubular adenoma with intraepithelial carcinoma. Note large pleomorphic, pale vesicular nuclei with large, prominent, irregular nucleoli (H&E, ×40).

Definitions. MTA: CRA with closed rings (microtubules) of dysplastic epithelium arranged lengthwise along the slopes of elongated outgrowths, in >50% of the adenomatous tissue (Figure 1).

Classification of MTA according to the degree of neoplastic severity: LGD: Dysplastic epithelium lined with spindle-shaped, rather uniform hyperchromatic nuclei, with regular nuclear membrane. Chromatin particles are uniformly small and the stratified nuclei do not exceed the deeper half of the epithelial thickness.

HGD: Dysplastic epithelium lined with spindle-shaped cells with hyperchromatic, pleomorphic nuclei. Chromatin particles are irregular with angular shapes, and the nuclear membrane is regular. Stratified nuclei exceed the superficial half of the epithelium and may reach the luminal epithelial border. Atypical mitoses are often present (Figure 2).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Microtubular adenoma with intramucosal invasion. Note microtubular pattern on top and lack of penetration of the muscularis mucosa at the bottom of the image (H&E, ×2).

IEC: Intraepithelial neoplastic epithelium exhibiting marked pleomorphic cells with swollen large vesicular (oval or round-shaped) nuclei, with bridges of nucleolus-associated chromatin reaching angular chromatin deposits both in the nucleus and on the nuclear membrane. Nucleolus is conspicuous (≥ 2.5 μm in diameter) and irregular and the nuclear membrane is often notched. The nuclear polarity is disrupted and atypical mitoses are found. Structural glandular alterations consist of budding or branching crypts or tubules with epithelial septa, back-to-back glands and cribriform growth. The glands are often arrayed obliquely to the basement membrane (Figure 3).

IMC: Adenoma with neoplastic cells with unquestionable invasion into the lamina propria mucosae. A desmoplastic reaction in the juxtaposing lamina propria and/or a neutrophilic infiltration may accompany that invasion (Figure 4).

SMC: Adenoma with neoplastic cells invading across the muscularis mucosae and unquestionably reaching the submucosal layer (Figure 5).

Advanced MTA: Regarded as those MTA exhibiting HGD, IEC, IMC or SMC.

This study was approved by the Ethics Committee, Department of Pathology, Karolinska University Hospital.

Statistical analysis. Comparison between groups was carried out using the Chi-square test; p<0.05 was regarded as significant.

Results

Out of 68 MTAs, 37 (54%) were found in males and the remaining 31 (46%) in females. The mean age of patients with MTA was 59 years (range=25-82 years); 25 (37%) were ≤59 years of age and the remaining 43 (63%), ≥60 years of age.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Microtubular adenoma with invasive carcinoma. Note that the invading tumor retains the microtubular features (H&E, ×10).

Out of the 68 MTAs, 64 (94.1%) were located in the left colon-rectum and the remaining four (5.9%) in the right colon (p<0.05).

Histological evaluation. Out of the 3,456 CRAs reviewed by CR, 58 (1.7%) were MTA. The review of the remaining 990 CRAs diagnosed by other pathologists at the Department, revealed that 10 CRAs initially diagnosed as TA (n=2), VA (n=5), or SA (n=3) were MTA at review. Hence, MTA accounted for 1.5% (n=68) of all CRAs (n=4446) seen at this Department between 2001 and 2010.

Table I shows that out of 68 MTAs, 55.9% had LGD, 25.0% HGD and 2.9% IEC. From Table I, 22 out of the 68 MTAs (32.3%) were advanced MTA.

The same Table also shows that out of 68 MTAs, 4.4% were IMCs and the remaining 11.8% were SMCs.

Discussion

In the present survey, MTA accounted for 1.5% of 4,446 CRA. Histology showed that 55.9% of the MTAs exhibited LGD, 25.0% HGD, 2.9% IEC, 4.4% IMC and the remaining 11.8% SMC. Advanced MTAs were found in 32.3% of the MTAs and SMC was recorded in 11.8%. These results validate previous results obtained in 1,552 CRA, in Florence, Italy (12, 13) where 35.7% of the MTAs were advanced MTAs, and 7.1% SMC. Thus, previous (12, 13) and present findings strongly suggest that MTAs are aggressive lesions with a propensity to evolve into invasive carcinoma.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Degree of neoplastic severity in 68 microtubular adenomas diagnosed during a 10-year period at a single hospital.

Fifty-four percent of the patients with MTA were males, and 63% were ≥60 years of age. These percentages are similar to those recorded in a cohort of Swedish patients with CRA, where all phenotypes of CRA were investigated (10). In that work, 52% of 3,135 CRAs were males and 65% were ≥60 years of age (10). It would appear that the development of MTA is neither influenced by the gender nor by the age of the patients.

According to the molecular paradigm of adenoma progression (39), genetic aberrations accumulate during the various phases of adenomatous growth, from TA with LGD and VA with HGD before invasive carcinoma ensues. It is to be understood that TSA or MTA were not included in the specific paradigm (39). Subsequently Yashiro et al. found loss of heterozygosity on 18q in TSA (40) suggesting a different molecular pathway for TSA on the one hand and TA and VA on the other.

In this work, the degree of cellular dysplasia and invasion into the lamina propria or in the submucosa were separately analyzed. This was done since progression of cellular neoplastic aberrations requires accumulation of genetic cell mutations (39), whereas penetration of the basement membrane by neoplastic cells requires collagen-degrading proteolytic enzymes, such as collagenase, plasminogen activator (41), heparanase (42), and matrilysin (43).

There is a plethora of literature concerning the cellular mutations that accumulate during carcinogenesis, but the molecular mechanisms that create morphological elements in CRA (TA, VA, SA, MTA) have received little attention. The Vogelstein paradigm (39) does not explain why CRA with disparate histological patterns often exhibit LGD (cf. Table I). The possibility that each histological type has its own molecular pathway of progression towards submucosal invasion cannot be totally excluded (36). On this respect, Harris et al. found that morphogenesis is controlled by the interaction between Sonic hedgehog and bone morphogenetic protein-2 (44). Based on this knowledge, it is speculated that the accumulation of cellular mutations leading to invasive carcinoma (39) (that is, carcinogenesis) might act independently of the series of molecular signals that orchestrate dysplastic crypts to adopt different structural configurations (that is, morphogenesis) (44). In this context, it should be mentioned that the administration of two different colonotropic carcinogens to two different strains of rats evoked different histological phenotypes of colonic adenoma with different biological behavior (45). Whether different carcinogens in the microenvironment induce different mutations in colorectal stem cells (46, 47) resulting in disparate architectural configurations such as those in TA, VA, TSA and MTA, remains unknown.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Percentage of microtubular adenomas recorded in 7,724 adenomas examined by the same observer (CR) in Sweden, Italy and Iceland.

Since the age of the patients was similar in MTA and other adenoma phenotypes (10), there was no indication that TA, VA or TSA had chronologically ‘re-modelled’ into MTA, or that TA, VA, TSA and MTA were transitional patterns capable of converting into a different phenotype with increasing age. Based on these considerations, several questions arise: i) Do MTA evolve, haphazardly in different individuals, or through a stochastic design of cell configuration orchestrated by epigenetic factors affecting susceptible individuals (46)? ii) Do environmental molecular signals program stem cells or more differentiated adenomatous cells to create tubular, villous, serrated or microtubular configurations (47)? iii) What are the molecular signals that instruct dysplastic cells to maintain the characteristic proliferation patterns in MTA (47)? iv) Are molecular signals being transferred from incipient adenomas back to stem cells, so that specific histological configurations can be replicated in subsequent dysplastic cell generations in the same adenoma (46)?

In 2008, Torlakovic et al. noted morphological features in TSA, such as filiform projections and ectopic crypt formations (48). The criteria and the illustrations in TSA with ectopic crypt formations in that publication are identical to those previously reported for MTA in Japanese (8), Swedish (10), Italian (13) and English (14) patients and subsequently endorsed by the WHO in 2000 (9).

TSAs are more commonly found in the left colon, and sessile serrated adenomas, characterized by serrated configurations, in the right colon (48). In the present study 94% of the MTAs were left-sided adenomas.

Previous studies on the histological phenotype in 7,724 colorectal adenomas (Table II) revealed that the frequency of MTA was similar in Sweden (10) (1%) and in Italy (12) (0.9%), but significantly higher in Iceland, namely 5.8% (Rubio and Jónasson, unpublished findings). In the light of this and the present results, we are inclined to speculate that the frequency of MTA might be influenced by genetic and/or epigenetic factors acting in different geographical regions.

In conclusion, due to distinctive microscopic and cell proliferative attributes, a predominant left-sided location, and the absence of serrated configurations, it is submitted that MTA is as a specific CRA phenotype, at variance with TA, VA, and TSA. The high frequency of SMC strongly suggests that MTA is an important alternative pathway in colorectal carcinogenesis. By including MTA amongst TSAs, the particularly aggressive behavior of MTA may be overlooked.

Footnotes

  • This article is freely accessible online.

  • Received October 14, 2013.
  • Revision received November 6, 2013.
  • Accepted November 8, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Ferlay J,
    2. Steliarova-Foucher E,
    3. Lortet-Tieulent J,
    4. Rosso S,
    5. Coebergh JW,
    6. Comber H,
    7. Forman D,
    8. Bray F
    : Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 49: 1374-1403, 2013.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Atkin WS,
    2. Saunders BP
    : Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 51(Suppl 5): V6-9, 2002
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lennard-Jones JE,
    2. Melville DM,
    3. Morson BC,
    4. Ritchie JK,
    5. Williams CB
    : Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years. Gut 31: 800-806, 2002.
    OpenUrl
  4. ↵
    1. Rubio CA,
    2. Lindh C,
    3. Bjork J,
    4. Törnblom H,
    5. Befrits R
    : Protruding and non-protruding colon carcinomas originating in gut-associated lymphoid tissue. Anticancer Res 30: 3019-3022, 2010.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Owen DA
    : Flat adenoma, flat carcinoma, and de novo carcinoma of the colon. Cancer 77: 3-6, 1996.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Shimoda T,
    2. Ikegami M,
    3. Fujisaki J,
    4. Matsui T,
    5. Aizawa S,
    6. Ishikawa E
    : Early colorectal carcinoma with special reference to its development de novo. Cancer 64: 1138-1146, 1989.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Rubio CA,
    2. Tanaka K,
    3. Befrits R
    : Traditional serrated adenoma in a patient with Barrett's esophagus. Anticancer Res 33: 1743-1745, 2013.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Kubo K,
    2. Kato Y,
    3. Rubio CA
    : Serrated colorectal adenomas. Endosc Digest 9: 559-563, 1997.
    OpenUrl
  9. ↵
    1. Hamilton S,
    2. Sobin LH,
    3. Kudo S,
    4. Rubio CA,
    5. Fogt F,
    6. Riboli E,
    7. Winawer S,
    8. Nakmura S,
    9. Goldgar D,
    10. Hainaut P,
    11. Jass J
    : Carcinoma of the colon and rectum: In: Pathology & Genetics. Tumours of the Digestive System. Lyon: IARC Press, 2000.
  10. ↵
    1. Rubio CA
    : Colorectal adenomas: Time for reappraisal. Pathol Res Pract 198: 615-620, 2002.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Rubio CA,
    2. Nesi G,
    3. Messerini L,
    4. Zampi G
    : Serrated and microtubular colorectal adenomas in Italian patients. A 5-year survey. Anticancer Res 25: 1353-1359, 2005.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Rubio CA
    : Serrated neoplasias and de novo carcinomas in ulcerative colitis: A histological study in colectomy specimens. J Gastroenterol Hepatol 22: 1024-1031, 2007.
    OpenUrlPubMed
  13. ↵
    1. Rubio CA,
    2. Nesi G,
    3. Messerini L,
    4. Zampi GC,
    5. Mandai K,
    6. Itabashi M,
    7. Takubo K
    : The Vienna classification applied to colorectal adenomas. J Gastroenterol Hepatol 21: 1697-703, 2006.
    OpenUrlPubMed
  14. ↵
    1. Rubio CA,
    2. Rodensjo M
    : Flat serrated adenomas and flat tubular adenomas of the colorectal mucosa: ifferences in the pattern of cell proliferation. Jpn J Cancer Res 86: 756-760, 1995.
    OpenUrl
  15. ↵
    1. Saeki T,
    2. Salomon D,
    3. Gullick W,
    4. Mandai K,
    5. Yamagami K,
    6. Moriwaki S,
    7. Takashima S,
    8. Nishikawa Y,
    9. Tahara E
    : Expression of cripto-1 in human colorectal adenomas and carcinomas is related to the degree of dysplasia. Int J Oncol 5: 445-451, 1994.
    OpenUrlPubMed
  16. ↵
    1. O'Brien MJ,
    2. Winawer SJ,
    3. Zauber AG,
    4. Gottlieb LS,
    5. Sternberg SS,
    6. Diaz B,
    7. Dickersin GR,
    8. Ewing S,
    9. Geller S,
    10. Kasimian D,
    11. National Polyp Study Workgroup
    : Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98: 371-379, 1990.
    OpenUrlPubMed
  17. ↵
    1. Adachi M,
    2. Ryan P,
    3. Collopy B,
    4. Fink R,
    5. Mackay J,
    6. Woods R,
    7. Okinaga K,
    8. Muto T,
    9. Moriaka Y
    : Adenoma–carcinoma sequence of the large bowel. Aust NZ J Surg 61: 409-414, 1991.
    OpenUrlPubMed
  18. ↵
    1. Gschwantler M,
    2. Kriwanek S,
    3. Langner E,
    4. Göritzer B,
    5. Schrutka-Kölbl C,
    6. Brownstone E,
    7. Feichtinger H,
    8. Weiss W
    : High-grade dysplasia and invasive carcinoma in colorectal adenomas: A multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 14: 183-188, 2002.
    OpenUrlCrossRefPubMed
    1. O'Brien MJ,
    2. Gibbons D
    : The adenoma–carcinoma sequence in colorectal neoplasia. Surg Oncol Clin N Am 5: 513-530, 1996.
    OpenUrlPubMed
  19. ↵
    1. Rubio CA,
    2. Kristjansdottir S,
    3. Thodleifsson B,
    4. Olafsdóttir E,
    5. Jonasson JG
    : The frequency of advanced adenoma in consulting patients: A nationwide survey in Iceland (2003-2006). Colorectal Dis 14: 595-602, 2012.
    OpenUrl
  20. ↵
    1. Jørgensen OD,
    2. Kronborg O,
    3. Fenger C,
    4. Rasmussen M
    : Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas). Acta Oncol 46: 355-360, 2007.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Ishii T,
    2. Notohara K,
    3. Umapathy A,
    4. Mallitt KA,
    5. Chikuba H,
    6. Moritani Y,
    7. Tanaka N,
    8. Rosty C,
    9. Matsubara N,
    10. Jass J,
    11. Leggett B,
    12. Whitehall V
    : Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas. Am J Surg Pathol 35: 212-220, 2011.
    OpenUrlPubMed
  22. ↵
    1. Bonithon-Kopp C,
    2. Piard F,
    3. Fenger C,
    4. Cabeza E,
    5. O'Morain C,
    6. Kronborg O,
    7. Faivre J,
    8. European Cancer Prevention Organisation Study Group
    . Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 47: 323-333, 2004.
    OpenUrlCrossRefPubMed
    1. Cordero C,
    2. Leo E,
    3. Cayuela A,
    4. Bozada JM,
    5. García E,
    6. Pizarro MA
    : Validity of early colonoscopy for the treatment of adenomas missed by initial endoscopic examination. Rev Esp Enferm Dig 93: 519-528, 2001.
    OpenUrlPubMed
  23. ↵
    1. Martínez ME,
    2. Sampliner R,
    3. Marshall JR,
    4. Bhattacharyya AK,
    5. Reid ME,
    6. Alberts DS
    : Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120: 1077-1083, 2001.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Nusko G,
    2. Hahn EG,
    3. Mansmann U
    : Risk of advanced metachronous colorectal adenoma during long-term follow-up. Int J Colorectal Dis 23: 1065-1071, 2008.
    OpenUrlPubMed
    1. Wong HL,
    2. Peters U,
    3. Hayes RB,
    4. Huang WY,
    5. Schatzkin A,
    6. Bresalier RS,
    7. Velie EM,
    8. Brody LC
    : Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer 46: 2457-2466, 2010.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Winawer SJ,
    2. Zauber AG,
    3. Fletcher RH,
    4. Stillman JS,
    5. O'brien MJ,
    6. Levin B,
    7. Smith RA,
    8. Lieberman DA,
    9. Burt RW,
    10. Levin TR,
    11. Bond JH,
    12. Brooks D,
    13. Byers T,
    14. Hyman N,
    15. Kirk L,
    16. Thorson A,
    17. Simmang C,
    18. Johnson D,
    19. Rex DK
    : Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 56: 143-159, 2006.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Denis B,
    2. Peters C,
    3. Chapelain C,
    4. Kleinclaus I,
    5. Fricker A,
    6. Wild R,
    7. Augé B,
    8. Gendre I,
    9. Perrin P,
    10. Chatelain D,
    11. Fléjou JF
    : Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur J Gastroenterol Hepatol 21: 1153-1160, 2009.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Noshirwani KC,
    2. van Stolk RU,
    3. Rybicki LA,
    4. Beck GJ
    : Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 51: 433-437, 2000.
    OpenUrlCrossRefPubMed
    1. Yamaji Y,
    2. Mitsushima T,
    3. Ikuma H,
    4. Watabe H,
    5. Okamoto M,
    6. Kawabe T,
    7. Wada R,
    8. Doi H,
    9. Omata M
    : Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 53: 568-572, 2004.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Wark PA,
    2. Wu K,
    3. van ‘t Veer P,
    4. Fuchs CF,
    5. Giovannucci EL
    : Family history of colorectal cancer: A determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer 125: 413-420, 2009.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Terry MB,
    2. Neugut AI,
    3. Bostick RM,
    4. Potter JD,
    5. Haile RW,
    6. Fenoglio-Preiser CM
    : Reliability in the Classification of Advanced Colorectal Adenomas. Cancer Epidemiol Biomarkers Prev 11: 660-603, 2002.
    OpenUrlAbstract/FREE Full Text
    1. Chaput U,
    2. Alberto SF,
    3. Terris B,
    4. Beuvon F,
    5. Audureau E,
    6. Coriat R,
    7. Roche H,
    8. Gaudric M,
    9. Prat F,
    10. Chaussade S
    : Risk factors for advanced adenomas amongst small and diminutive colorectal polyps: A prospective monocenter study. Digest Liver Dis 43: 609-612, 2011.
    OpenUrl
  30. ↵
    1. Lakis S,
    2. Papamitsou T,
    3. Panagiotopoulou C,
    4. Kotakidou R,
    5. Kotoula V
    : AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas. World J Gastroenterol 16: 2476-2483, 2010.
    OpenUrlPubMed
  31. ↵
    1. Rubio CA,
    2. Delinassios JG
    : Invasive carcinomas may arise in colorectal adenomas with high-grade dysplasia and with carcinoma in situ. Int J Clin Exp Med 3: 41-47, 2010.
    OpenUrlPubMed
  32. ↵
    1. Rubio CA
    : Qualitative DNA differences between two structurally different lesions: High-grade dysplasia and carcinoma in situ in colorectal adenomas. Anticancer Res 27: 2881-2885, 2007.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Rubio CA
    : Difference in cell proliferation between two structurally different lesions in colorectal adenomas: high-grade dysplasia and carcinoma in situ. Anticancer Res 27: 4321-4324, 2007.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Vogelstein B,
    2. Fearon ER,
    3. Hamilton SR,
    4. Kern SE,
    5. Preisinger AC,
    6. Leppert M,
    7. Nakamura Y,
    8. White R,
    9. Smits AM,
    10. Bos JL
    : Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-528, 1988.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Yashiro M,
    2. Laghi L,
    3. Saito K,
    4. Carethers JM,
    5. Slezak P,
    6. Rubio C A,
    7. Hirakawa K,
    8. Boland CR
    : Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. Cancer Epidemiol Biomarkers Prev 14: 2253-2256, 2005.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Salo T,
    2. Liotta LA,
    3. Keski-Oja J,
    4. Turpeenniemi-Hujanen T,
    5. Tryggvason K
    : Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells–role in metastasis. Int J Cancer 30: 669-673, 1982.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Xie ZJ,
    2. Liu Y,
    3. Jia LM,
    4. He YC
    : Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer. World J Gastroenterol 14: 3812-3818, 2008.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Masaki T,
    2. Matsuoka H,
    3. Sugiyama M,
    4. Abe N,
    5. Goto A,
    6. Sakamoto A,
    7. Atomi Y
    : Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84: 1317-1321, 2001.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Harris MP,
    2. Williamson S,
    3. Fallon JF,
    4. Meinhardt H,
    5. Prum RO
    : Molecular evidence for an activator-inhibitor mechanism in development of embryonic feather branching. Proc Natl Acad Sci USA 102: 11734-11739, 2005.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Rubio CA,
    2. Takayama S
    : Difference in histology and size in colonic tumors of rats receiving two different carcinogens. J Environ Pathol Toxicol Oncol 13: 191-197, 1994.
    OpenUrlPubMed
  41. ↵
    1. Singh SR
    1. Rubio CA
    : Putative Stem Cells in Mucosas of the Esophago-Gastrointestinal Tract. Chapter 10. In: Stem Cell, Regenerative Medicine and Cancer. Singh SR (ed.) Nova Science Publishers, Inc. Haupauge, NY, USA, pp. 279-308, 2011.
  42. ↵
    1. Singh SR
    1. Rubio CA
    : Signaling pathways, gene regulation and duodenal neoplasias. Chapter 6. In: Signaling, Gene Regulation and Cancer. Singh SR (ed.) Nova Science Publishers, Inc. Haupauge, NY, USA, pp. 83-110, 2013.
  43. ↵
    1. Torlakovic EE,
    2. Gomez JD,
    3. Driman DK
    : Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32: 21-29, 2008.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 33 (12)
Anticancer Research
Vol. 33, Issue 12
December 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advanced Microtubular Colorectal Adenomas: A 10-Year Survey at a Single Hospital
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Advanced Microtubular Colorectal Adenomas: A 10-Year Survey at a Single Hospital
CARLOS A. RUBIO, EDGAR JARAMILLO
Anticancer Research Dec 2013, 33 (12) 5471-5476;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Advanced Microtubular Colorectal Adenomas: A 10-Year Survey at a Single Hospital
CARLOS A. RUBIO, EDGAR JARAMILLO
Anticancer Research Dec 2013, 33 (12) 5471-5476;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Updated Histologic Classification of Adenomas and Carcinomas in the Colon of Carcinogen-treated Sprague-Dawley Rats
  • Traditional serrated adenomas and serrated carcinomas in carcinogen-treated rats
  • Two Phenotypes of Traditional Serrated Adenomas Nationwide Survey in Iceland
  • p53 Up-regulation During Colorectal Carcinogenesis
  • An Additional Case of Gastric Serrated Adenoma
  • Google Scholar

More in this TOC Section

  • Triage Process at Endoscopy With ColonView Fecal Immunochemical Test (FIT) Will Enhance Diagnostic Accuracy (DA) of Colorectal Cancer Screening
  • Laparoscopic Colorectal Cancer Surgery for Patients With Severe Chronic Heart Failure
  • Clinical Impact of Prehabilitation on Elective Laparoscopic Surgery in Frail Octogenarians With Colorectal Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Advanced adenomas
  • microtubular configurations
  • invasive carcinoma
  • colorectal adenoma
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire